Recently, we showed that ASGR1 as a tumor suppressor could inhibit STAT3 activation by interacting with NLK in HCC cells.25 The current study reported the identification of DBF4 as another important factor to modulate STAT3 activity. The gene discussed is DBF4; the disease is neoplasm.